300653 Yantai Zhenghai Bio-Tech
- 22.45
- -0.54-2.35%
About Yantai Zhenghai Bio-Tech Company
The company was founded in 2003 and successfully listed on May 16, 2017. It is a national key R&D project undertaker, a national “863” plan undertaker, and a high-tech enterprise. The company is based in the field of regenerative medicine and is in the “13th Five-Year Plan” strategic emerging industry. It has passed ISO13485/ISO9001 quality management system certification. The company has high-standard regenerative medicine materials research platforms such as the Shandong Medical Regenerative Repair Materials Engineering Technology Research Center, the Shandong Enterprise Technology Center, and the Shandong Biological Regenerative Materials Engineering Laboratory. The company's main business is R&D, production and sales of bio-regenerated materials. The main products include oral repair films, absorbable hard brain (ridge) membrane patches, bone repair materials, skin repair films, surgical filling sponges, self-acid corrosion adhesives, active biological bone, hard brain (ridge) membrane patches, phosphoric acid corrosion agents, dental fissure sealants, light-curing composite resins, etc. Honors: The company passed the national high-tech enterprise review certification, won honors such as the 2023 National Intelligent Manufacturing Excellent Scenario, the 2023 Shandong “Quality Lu Yao” Construction Demonstration Enterprise, and was approved as a platform title such as the Shandong Engineering Research Center and Yantai Green Factory. The company's trademark brand was selected as the national “Thousand Enterprises and 100 Cities” trademark brand value enhancement action list. The company's Haiao Dental Repair Mask won the title of Qilu Premium Made in Shandong Province, Shandong Quality Brand Construction Excellent Product, Shandong Quality Brand. The company has successively won Shandong High-end Brand Cultivation Enterprise and Yantai City The Mayor's Quality Award won the 2024 Yantai Intelligent Manufacturing Outstanding Scenario; it was listed on the “2024 China Brand Value Evaluation Information” jointly published by Xinhua News Agency, China Brand Building Promotion Association, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- huanxiang guo
- Chairman, Directors, Member of the Remuneration and Assessment Committee, Chairman of the Strategy and Investment Committee
- --
- Qun Dong
- Vice Chairman, Directors
- --
- ting ni
- Directors
- --
- kan song
- Directors, General Manager, Member of the Strategy and Investment Committee
- 1.12M
- chao zhang
- Directors, Member of the Strategy and Investment Committee, Nomination Committee Members, Audit Committee Member
- --
- li zhao
- Directors, Board Secretary, Deputy General Manager, Chief Financial Officer
- 904.90K
- xiliang song
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Member of the Strategy and Investment Committee
- 60.00K
- jianghua li
- Independent Directors, Nomination Committee Members
- --
- hui wang
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Member of the Strategy and Investment Committee, Chairman of the Nomination Committee
- --
- yangqiong lv
- Securities Affairs Representative
- --
- yueli xu
- Chairman of the Supervisory Board, Auditors
- --
- lishan pan
- Auditors
- 30.00K
- donggang zhang
- Deputy General Manager, Chief engineer, Director of R&D Division II
- 907.90K
- xing yang
- Deputy General Manager
- 1.52M
- guangping song
- Employee Supervisors
- --
Analysis
Price Target
No Data
No Data